Immunology and barrier function of the skin

Kanerva's Occupational Dermatology, Second Edition

Volumn 1, Issue , 2012, Pages 3-8

  Rustemeyer, Thomas ^a   Fartasch, Manigé ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84877965968     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-02035-3_1     Document Type: Chapter

References (56)

1. Agner T, Johansen JD, Overgaard L et al (2002) Combined effects of irritants and allergens. Synergistic effects of nickel and sodium lauryl sulfate in nickel- sensitized individuals. Contact Dermatitis 47:21-26
2. Basketter DA, Kan-King-Yu D, Dierkes P et al (2007) Does irritation potency contribute to the skin sensitization potency of contact allergens? Cutan Ocul Toxicol 26:279-286
3. Bauer J, Bahmer FA, Worl J et al (2001) A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereologic study using the optical disector method and the confocal laser scanning microscope. J Invest Dermatol 116:313-318
4. Blomeke B, Brans R, Dickel Hetal (2008) Association between TNFA-308 G/A polymorphism and sensitization to para-phenylenediamine: a case-control study. Allergy 64(2):279-283
5. Bonneville M, Chavagnac C, Vocanson M et al (2007) Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol 127:1430-1435
6. Bouwstra JA, Ponec M (2006) The skin barrier in healthy and diseased state. Biochim Biophys Acta 1758:2080-2095
7. Brasch J, Burgard J, Sterry W (1992) Common pathogenetic pathways in allergic and irritant contact dermatitis. J Invest Dermatol 98:166-170
8. Callard RE, Harper JI (2007) The skin barrier, atopic dermatitis and allergy: a role for Langerhans cells? Trends Immunol 28:294-298
9. Chavanas S, Bodemer C, Rochat A et al (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141-142
10. de Jongh CM, Jakasa I, Verberk MM et al (2006) Variation in barrier impairment and inflammation of human skin as determined by sodium lauryl sulphate penetration rate. Br J Dermatol 154:651-657
11. de Jongh CM, Lutter R, Verberk MM et al (2007) Differential cytokine expression in skin after single and repeated irritation by sodium lauryl sulphate. Exp Dermatol 16:1032-1040
12. de Jongh CM, John SM, Bruynzeel DP et al (2008a) Cytokine gene polymorphisms and susceptibility to chronic irritant contact dermatitis. Contact Dermatitis 58:269-277
13. de Jongh CM, Khrenova L, Kezic S et al (2008b) Polymorphisms in the interleukin-1 gene influence the stratum corneum interleukin-1 alpha concentration in uninvolved skin of patients with chronic irritant contact dermatitis. Contact Dermatitis 58:263-268
14. Elias PM, Feingold KR (2006) Permeability barrier homeostasis. In: Elias PM, Feingold KR (eds) Skin barrier. Taylor and Francis, New York \London
15. Fartasch M (1997) Epidermal barrier in disorders ofthe skin. Microsc Res Tech 38:361-372
16. Fartasch M (2004) The epidermal lamellar body: a fascinating secretory organelle. J Invest Dermatol 122: XI-XII
17. Fartasch M (2005) Atopic dermatitis and other skin diseases. In: Fluhr J, Elsner P, Berardesca E, Maibach F (eds) Bioengineering of the skin: water and stratum corneum, 2nd edn. Crc Press, Boca Raton, pp 160-169
18. Fartasch M, Schnetz E, Diepgen TL (1998) Characterization of detergent-induced barrier alterations - effect of barrier cream on irritation. J Investig Dermatol Symp Proc 3:121-127
19. Fartasch M, Williams ML, Elias PM (1999) Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol 135:823-832
20. Friedmann PS (2006) Contact sensitisation and allergic contact dermatitis: immunobiological mechanisms. Toxicol Lett 162:49-54
21. Friedmann PS (2007) The relationships between exposure dose and response in induction and elicitation of contact hypersensitivity in humans. Br J Dermatol 157:1093-1102
22. Friedmann PS, Moss C, Shuster S et al (1983) Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin Exp Immunol 53:709-715
23. Gallucci S, Lolkema M, Matzinger P (1999) Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5:1249-1255
24. Grabbe S, Steinert M, Mahnke K et al (1996) Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis. J Clin Invest 98:1158-1164
25. Hoath S (2001) The skin as a neurodevelopmental interface. Neo Rev 2:269-281
26. Hudson TJ (2006) Skin barrier function and allergic risk. Nat Genet 38:399-400
27. Incorvaia C, Frati F, Verna N et al (2008) Allergy and the skin. Clin Exp Immunol 153(1):27-29
28. Jacobs JJ, Lehe CL, Cammans KD et al (2004) Assessment of contact allergens by dissociation of irritant and sensitizing properties. Toxicol In Vitro 18:681-690
29. Jacobs JJ, Lehe CL, Hasegawa H, Das PK et al (2006) Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol 15:432-440
30. Jakasa I, de Jongh CM, Verberk MM et al (2006) Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol 155:104-109
31. Jensen JM, Folster-Holst R, Baranowsky A et al (2004) Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 122:1423-1431
32. Johansen JD, Skov L, Volund A et al (1998) Allergens in combination have a synergistic effect on the elicitation response: a study of fragrance-sensitized individuals. Br J Dermatol 139:264-270
33. Judge MR, Griffiths HA, Basketter DA et al (1996) Variation in response of human skin to irritant challenge. Contact Dermatitis 34:115-117
34. Kezic S (2008) Methods for measuring in-vivo percutaneous absorption in humans. Hum Exp Toxicol 27:289-295
35. Kimber I, Dearman RJ, Gerberick GF et al (2003) Designation of substances as skin sensitizing chemicals: a commentary. Hum Exp Toxicol 22:439-443
36. McFadden JP, Basketter DA (2000) Contact allergy, irritancy and “danger”. Contact Dermatitis 42:123-127
37. McLelland J, Shuster S, Matthews JN (1991) “Irritants” increase the response to an allergen in allergic contact dermatitis. Arch Dermatol 127: 1016-1019
38. Menon GK (2003) Caveolins in epidermal lamellar bodies: skin is an interactive interface, not an inflexible barrier. J Invest Dermatol 120: XV-XVI
39. Menon G, Fartasch M (2010) Structural and functional correlations of skin barrier in health and disease: models and evaluation. In: Monteiro-Riviere NA (ed) Toxicology of the skin: targets organ series. Informa Healthcare, New York
40. Nickoloff BJ, Naidu Y (1994) Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30:535-546
41. Nishijima T, Tokura Y, Imokawa G et al (1997) Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption. J Invest Dermatol 109:175-182
42. Novak N, Baurecht H, Schafer T et al (2008) Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 128:1430-1435
43. O’Reagan GM, Irvine AD (2008) The role of filaggrin loss-of-function mutations in atopic dermatitis. Curr Opin Allergy Clin Immunol 8(5):406-410
44. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441-446
45. Pedersen LK, Johansen JD, Held E (2004) Augmentation of skin response by exposure to a combination of allergens and irritants - a review. Contact Dermatitis 50:265-273
46. Proksch E, Brasch J (1997) Influence of epidermal permeability barrier disruption and Langerhans’ cell density on allergic contact dermatitis. Acta Derm Venereol 77:102-104
47. Proksch E, Elias PM, Feingold KR (1990) Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. J Clin Invest 85:874-882
48. Saint-Mezard P, Rosieres A, Krasteva M et al (2004) Allergic contact dermatitis. Eur J Dermatol 14:284-295
49. Tsai JC, Feingold KR, Crumrine D et al (1994) Permeabilitybarrier disruption alters the localization and expression ofTNF alpha/protein in the epidermis. Arch Dermatol Res 286:242-248
50. Uter W, Schnuch A, Geier J et al (1998) Epidemiology of contact dermatitis. The information network of departments of dermatology (IVDK) in Germany. Eur J Dermatol 8:36-40
51. von den Driesch P, Fartasch M, Huner A et al (1995) Expression of integrin receptors and ICAM-1 on keratinocytes in vivo and in an in vitro reconstructed epidermis: effect of sodium dodecyl sulphate. Arch Dermatol Res 287:249-253
52. Warner RR, Bush RD, Ruebusch NA (1995) Corneocytes undergo systematic changes in element concentrations across the human inner stratum corneum. J Invest Dermatol 104:530-536
53. Westphal GA, Schnuch A, Moessner R et al (2003) Cytokine gene polymorphisms in allergic contact dermatitis. Contact Dermatitis 48:93-98
54. Willis CM, Shaw S, De Lacharri6re O et al (2001) Sensitive skin: an epidemiological study. Br J Dermatol 145(2):258-263
55. Wilmer JL, Burleson FG, Kayama F et al (1994) Cytokine induction in human epidermal-keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J Invest Dermatol 102:915-922
56. Wood LC, Jackson SM, Elias PM et al (1992) Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-487